Research Highlights

 
Stock Quotes for Research Highlights top ^
  • Industry: Apparel Manufacturing
  • Sector: Consumer Cyclical
  • Stock Style: Small Core
Sign-up for 01682 investment picks
  • Industry: Lodging
  • Sector: Consumer Cyclical
  • Stock Style: Small Core
Sign-up for l60 investment picks
  • Industry: Media - Diversified
  • Sector: Consumer Cyclical
  • Stock Style: Small Core
Sign-up for hlg investment picks

 
News Articles for Research Highlights top ^
2015/1/28
http://www.marketwire.com/library/MwGo/2015/1/27/11G031521/861ee27ae538817a_org-1695662627.jpg COLUMBUS, OH--(Marketwired - January 28, 2015) - Leading family media brand and publisher of the best-read children's magazines in North America, Highlights for Children Inc. today joined MEGA® Brands Inc., a member of the Mattel family of companies (NASDAQ: MAT), in announcing a multi-year licensing partnership to develop a new line of puzzles featuring Highlights' popular Hidden Pictures™ illustrations.
Sign-up for Highlights for Children and MEGA Brands a Great Fit in New Kids Puzzles Partnership investment picks
2015/2/2
4 th Quarter Highlights : 2014 Highlights : Earnings of $103.7 million represent a 2.7% increase over 2013 ($100.9 million) and the highest net income since 2002 Organic loan growth of $339.6 million or 7.0% Completed acquisitions in the higher growth markets of Fort Wayne and Lafayette, Indiana and Ann Arbor, Michigan Credit quality and capital levels remained strong EVANSVILLE, Ind., Feb.
Sign-up for Strong Earnings and Successful Acquisitions Highlight Transformational Year for Old National Bancorp investment picks
2015/2/17
Capstone Mining 2014 Financial Results Highlight Significant Cash Flow Generation Canada NewsWire Operating cash flow before changes in working capital of $199.4 million (All amounts in US$ unless otherwise specified) VANCOUVER , Feb.
Sign-up for Capstone Mining 2014 Financial Results Highlight Significant Cash Flow Generation investment picks
2015/1/11
XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.S. Food and Drug Administration (FDA) on development for treatment of alcohol use disorder (AUD). HORIZANT prescription trend highlights include: The number of nation-wide prescribed tablets for the 13 weeks ending December 19, 2014 was 1,256,082, an increase of 18% compared to the prior 13 weeks ending September 19, 2014 and an increase of 95% over the 13-week period ending December 20, 2013.* The rolling four-week average of prescribed tablets for the week ending December 19, 2014 was 100,742.* The current wholesale acquisition cost (WAC) price is $7.69 per tablet.
Sign-up for XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder investment picks
2015/2/17
Killam Properties Inc. announces Q4 and year-end 2014 results highlighting FFO per share (diluted) of $0.72 for the year and increased geographic diversification Canada NewsWire HALIFAX , Feb.
Sign-up for Killam Properties Inc. announces Q4 and year-end 2014 results highlighting FFO per share (diluted) of $0.72 for the year and increased geographic diversification investment picks
2015/2/18
- Achieved Key 2014 'Clinical Map Initiative' Goals to Advance microRNA Therapeutics Pipeline - - Exceeded Guidance Ending 2014 with $159.7 Million in Cash - LA JOLLA, Calif.
Sign-up for Regulus Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights investment picks
2015/2/17
Operating cash flow before changes in working capital of $199.4 million (All amounts in US$ unless otherwise specified) VANCOUVER , Feb.
Sign-up for Capstone Mining 2014 Financial Results Highlight Significant Cash Flow Generation investment picks
2015/2/10
Katanga Mining Announces 2014 Year End Operational Highlights Canada NewsWire ZUG, Switzerland , Feb.
Sign-up for Katanga Mining Announces 2014 Year End Operational Highlights investment picks
2014/12/9
Pfizer Inc. (NYSE:PFE) today announced the presentation of encouraging early- and late-stage data from clinical studies across several hematologic malignancies, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML). Among the highlights are results from several investigator-led, large, randomized studies evaluating the antibody-drug conjugate (ADC) MYLOTARG (gemtuzumab ozogamicin) in select adult AML populations.
Sign-up for New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers investment picks
2014/12/9
GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that data from research related to the company’s E-Selectin antagonist (GMI-1271), focusing on its potential in treating blood cancers and coagulation disorders, were highlighted this week through four oral presentations and one poster session at the 2014 American Society of Hematology Annual Meeting in San Francisco.
Sign-up for GlycoMimetics Highlights Potential Therapeutic Benefits of Its Novel E-Selectin Antagonist at 56th ASH Annual Meeting investment picks
2014/12/8
Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted multiple ADCETRIS (brentuximab vedotin) data presentations in frontline and salvage Hodgkin lymphoma (HL) at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition taking place in San Francisco, CA, December 6-9, 2014.
Sign-up for Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting investment picks
2014/12/11
EDISON, N.J. , Dec.
Sign-up for ContraVir Pharmaceuticals' CEO Issues Letter to Shareholders Highlighting Significant Progress investment picks
2015/1/5
http://www.marketwire.com/library/MwGo/2015/1/5/11G029516/WinnebagoIND_red_TM-625615462357.jpg FOREST CITY, IA--(Marketwired - January 05, 2015) - Winnebago Industries, Inc. (NYSE: WGO), a leading United States (U.S.) recreation vehicle manufacturer and the world's #1 manufacturer of Mercedes Sprinter-based motorhomes, is releasing a new video today highlighting a test drive comparison between the V6 Mercedes chassis versus the new in-line four-cylinder I-4 turbo-diesel Mercedes chassis.
Sign-up for Winnebago Video Highlights Mercedes Chassis Test Drive investment picks
2014/12/17
Rising geopolitical tensions, political violence, and separatist movements combined with falling commodity prices are exacerbating political risks and further highlighting challenges for direct foreign investors, according to the 2015 Political Risk Map and report , released today by Marsh, a global leader in insurance broking and risk management.
Sign-up for Marsh’s 2015 Political Risk Map Highlights Challenges for Foreign Investors investment picks
2015/1/21
UnitedHealth Group (NYSE:UNH) today reported fourth quarter and full year 2014 results, highlighted by Optum’s exceptional revenue growth, margin expansion and earnings advances and broad-based strength in UnitedHealthcare’s public and senior sector benefits business.
Sign-up for UnitedHealth Group Reports 2014 Results, Highlighted by Strength in Growth Markets investment picks
2015/1/28
During its annual shareholder meeting in Austin, Minn., Hormel Foods Corporation (NYSE: HRL), a multinational marketer of consumer-branded food and meat products, celebrated a record fiscal year 2014, and highlighted the company’s foodservice business under its Refrigerated Foods segment.
Sign-up for Hormel Foods Celebrates Record Year and Highlights Foodservice Channel Growth at Annual Shareholder Meeting investment picks
2015/1/22
XI'AN, China , Jan.
Sign-up for China Recycling Energy Corporation Issues Preliminary Fourth Quarter and Full Year 2014 Financial Highlights investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Highlights
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Guides  |  Next: Research Hospital